Coronavirus et pathologie cardiovasculaire.

Titre original : 
Cardiovascular Considerations for Patients, Health Care Workers, and Health sculaire.Systems During the Coronavirus Disease
Titre en français : 
Coronavirus et pathologie cardiovasculaire.
Auteurs : 
Elissa Driggin, MD, Mahesh V. Madhavan, MD, Behnood Bikdeli, MD, MS, Taylor Chuich, PharmD, Justin Laracy, MD, Giuseppe Bondi-Zoccai, MD, MStat, Tyler S. Brown, MD, Caroline Der Nigoghossian, PharmD, David A. Zidar, MD, PhD, Jennifer Haythe, MD, Daniel Brodie, MD, Joshua A. Beckman, MD, Ajay J. Kirtane, MD, SM, Gregg W. Stone, MD, Harlan M. Krumholz, MD SM, Sahil A. Parikh, MD
Revue : 
JACC March 2020




Résumé : 

The coronavirus disease-2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 that has significant implications for the cardiovascular care of patients. First, those with COVID-19 and preexisting cardiovascular disease (CVD) have an increased risk of severe disease and death. Second, infection has been associated with multiple direct and indirect cardiovascular complications including acute myocardial injury, myocarditis, arrhythmias and venous thromboembolism. Third, therapies under investigation for COVID-19 may have cardiovascular side effects. Fourth, the response to COVID-19 can compromise the rapid triage of non-COVID-19 patients with cardiovascular conditions. Finally, the provision of cardiovascular care may place health care workers in a position of vulnerability as they become host or vectors of virus transmission. We hereby review the peer-reviewed and preprint literature pertaining to cardiovascular considerations related to COVID-19 and highlight gaps in knowledge that require further study pertinent to patients, health care workers, and health systems.